Sihuan Pharmaceutical holding Group Co., Ltd. is a Hong Kong investment holding company engaged in pharmaceutical business. The company is mainly engaged in drug research and development, manufacturing and sales in China. Its products cover cardio-cerebrovascular, central nervous system, metabolism, tumor and anti-infection fields. Its products include cardiovascular and cerebrovascular products such as Klingo, Agili and Odime, as well as non-cardiovascular and cerebrovascular products such as Renao, metronidazole and roxatidine.
CEO： Fengsheng Che
Market： Hong Kong motherboard